Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RAB25 |
| Upstream (Parents) |
|---|
| (<<) SPINT1 → RAB25 |
| (<<) GPR35 → RAB25 |
| (<<) S100P → RAB25 |
| Downstream (Children) |
|---|
| RAB25 → C1orf116 (>>) |
| RAB25 → TSPAN15 (>>) |
| RAB25 → PRSS3 (>>) |
| RAB25 → CALML4 (>>) |
| RAB25 → CDCP1 (>>) |
| RAB25 → AP1M2 (>>) |
| RAB25 → GALNT3 (>>) |
| RAB25 → ADAP1 (>>) |
| RAB25 → DPH2 (>>) |
| RAB25 → S100A6 (>>) |
| RAB25 → LAD1 (>>) |
| RAB25 → PLP2 (>>) |
| RAB25 → PPAP2C (>>) |
| RAB25 → SH3GLB2 (>>) |
| RAB25 → RAB11FIP1 (>>) |
| RAB25 → ITGB8 (>>) |
| RAB25 → CXCL3 (>>) |
| RAB25 → PIP5K1B (>>) |
| RAB25 → C3orf52 (>>) |
| RAB25 → PTK6 (>>) |
| RAB25 → S100A10 (>>) |
| RAB25 → STK39 (>>) |
| RAB25 → CBX8 (>>) |
| RAB25 → SLC37A1 (>>) |
| RAB25 → MST1R (>>) |
| RAB25 → PURA (>>) |
| RAB25 → PKP3 (>>) |
| RAB25 → GPR35 (>>) |
| RAB25 → SLC12A2 (>>) |
| RAB25 → EPPK1 (>>) |
| RAB25 → SERPINB5 (>>) |
| RAB25 → MYB (>>) |
| RAB25 → S100P (>>) |
| RAB25 → C19orf21 (>>) |
| RAB25 → BIK (>>) |
